ViaLase
Corona Del Mar
About ViaLase
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma. The company's system focuses on the development of micron-resolution OCT image-guided femtosecond laser technology to create micron-sized customized drainage channels through the trabecular meshwork that connects the anterior chamber to the Schlemm's canal without surgically opening or penetrating the eye, enabling medical professionals to improve glaucoma management with its efficient non-invasive treatment. ViaLase was incorporated in 2019 and is headquartered in Corona Del Mar, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $78.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2024)
- Website: vialase.com
- Phone: 949-538-6623
Industries & Categories
Health Care, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/vialase-95780 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.